Myelofibrosis | Oncology Today with Dr Neil Love: Novel Agents and Strategies in Myelofibrosis (Companion Faculty Lecture)

from Research To Practice | Oncology Videos · host Dr. Neil Love

Featuring a slide presentation and related discussion from Dr Ruben Mesa, including the following topics: Efficacy and safety of FDA-approved JAK inhibitors for the management of myelofibrosis (MF) (0:00) Emerging JAK inhibitors under Phase III evaluation for MF (6:59) Current guidelines and strategies for managing MF (13:53) Emerging data with novel agents and strategies for MF (17:31) Splenic response and symptomology in patients with MF (25:36) CME information and select publications

Episode metadata supplied by the publisher feed · Published Dec 1, 2022

Embed this episode

Attribution link and audio player

Ready to play

Myelofibrosis | Oncology Today with Dr Neil Love: Novel Agents and Strategies in Myelofibrosis (Companion Faculty Lecture)

0:00 32:49

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Research To Practice | Oncology Videos?

This episode is 32 minutes long.

When was this Research To Practice | Oncology Videos episode published?

This episode was published on December 1, 2022.

Can I download this Research To Practice | Oncology Videos episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!